A favorable metabolic and antiatherogenic profile in carriers of CYP21A2 gene mutations supports the theory of a survival advantage in this population.
| Image |  |
|---|---|
| Description | scientific article published on 21 October 2009 |
| Author/s |
author: Sarantis Livadas Georgios P. Chrousos |
| Publication date | October 21, 2009 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |